ID

27984

Description

ADVANCED PROSTATE CANCER DATA COLLECTION Version 2.3.1 Revised: April 10th, 2017, International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Conditions:All patients with advanced prostate cancer, either having metastatic disease or biochemical recurrence progressing after salvage treatment or ineligible for salvage treatment. Patients with biochemical recurrence treated with salvage therapy are referred to the localized prostate cancer set Treatment Approaches: Hormonal Therapy | Chemotherapy | Immunotherapy | Radiopharmaceuticals | Radiation | Interventions for Complications of Local Progression Questionnaires used in this form: Expanded Prostate Cancer Index Composite (EPIC-26) The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed. Refer to http:// dx.doi.org/10.1016/j.urology.2006.01.077 for more information

Link

http://www.ichom.org/

Keywords

Versions (4)
  1. 12/7/17 12/7/17 -
  2. 11/29/18 11/29/18 - Sarah Riepenhausen
  3. 11/29/18 11/29/18 - Sarah Riepenhausen
  4. 4/30/20 4/30/20 - Sarah Riepenhausen
Copyright Holder

ICHOM

Uploaded on

December 7, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

ICHOM Advanced Prostate Cancer

English

ICHOM Advanced Prostate Cancer

1 forms  
Advanced Prostate Cancer
Description

Advanced Prostate Cancer

Indicate the patient's medical record number
Description

This number will not be shared with ICHOM. In the case patient-level data is submitted to ICHOM for benchmarking or research purposes, a separate ICHOM Patient Identifier will be created and cross-linking between the ICHOM Patient Identifier and the medical record number will only be known at the treating institution INCLUSION CRITERIA: All patients TIMING: On all forms REPORTING SOUCE: Administrative or clinical RESPONSE OPTIONS: According to institution

Data type

integer

Alias
UMLS CUI [1]
C1269815
Demographic factors
Description

Demographic factors

What is your date of birth?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical or patient-reported

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1]
C0421451
DD/MM/YYYY
Indicate height in centimeters or inches
Description

Height and weight are used to calculate BMI INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical reported RESPONSE OPTIONS: Numerical value of height in cm or in

Data type

integer

Alias
UMLS CUI [1]
C0005890
Indicate units of height
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0005890
UMLS CUI [1,2]
C1519795
Indicate weight in kilograms or pounds
Description

Height and weight are used to calculate BMI INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical reported RESPONSE OPTIONS: Numerical value of weight in kg or lbs

Data type

integer

Alias
UMLS CUI [1]
C0005910
Indicate units of weight
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0005910
UMLS CUI [1,2]
C1519795
What is your height in centimeters or inches?
Description

Height and weight are used to calculate BMI INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported RESPONSE OPTIONS: Numerical value of height in cm or in

Data type

integer

Alias
UMLS CUI [1]
C0005890
Indicate units of height
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1,1]
C0005890
UMLS CUI [1,2]
C1519795
What is your weight in kilograms or pounds?
Description

Height and weight are used to calculate BMI INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported RESPONSE OPTIONS: Numerical value of weight in kg or lbs

Data type

integer

Alias
UMLS CUI [1]
C0005910
Indicate units of weight f
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0005910
UMLS CUI [1,2]
C1519795
Varies by country and should be determined by country (not for cross country comparison)
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

text

Alias
UMLS CUI [1]
C0015031
Please indicate highest level of schooling completed
Description

The level of schooling is defined in each country as per ISCED [International Standard Classification] INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0013658
What is your relationship status?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0024819
Which statement best describes your living arrangements?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0024819
Baseline Clinical Factors
Description

Baseline Clinical Factors

Indicate hemoglobin level at time of APC diagnosis
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical RESPONSE OPTIONS: Numerical value of hemoglobin level in g/L

Data type

integer

Alias
UMLS CUI [1,1]
C0518015
UMLS CUI [1,2]
C0011900
Have you been told by a doctor that you have any of the following?
Description

Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Multiple answer Separate multiple entries with "";""

Data type

integer

Alias
UMLS CUI [1]
C0009488
On a scale of 0 to 10, with 0 being no pain at all and 10 being the worst pain imaginable, please indicate your average pain over the last 7 days?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported RESPONSE OPTIONS: Ordinal values from 0 to 10, with 'No pain' marked at '0' and 'Worst pain imaginable' marked at '10'

Data type

integer

Alias
UMLS CUI [1]
C0582148
Do you have a first degree relative (father, brother, son) with a prostate cancer diagnosis?
Description

A first degree relative is a father, brother, or son INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C1532320
Baseline Tumor Factors
Description

Baseline Tumor Factors

Indicate PSA value at time of APC diagnosis
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical RESPONSE OPTIONS: Numerical value of PSA ng/mL

Data type

integer

Alias
UMLS CUI [1]
C0201544
Indicate the clinical tumor stage (per AJCC 7th)
Description

Pathologic staging preferred, if available cT0: No evidence of primary tumor cT1: if not able to select T1a, T1b or T1c: Clinically inapparent tumor neither palpable nor visible by imaging cT1a: Tumor incidental histologic finding in 5 percent or less of tissue resected cT1b: Tumor incidental histologic finding in more than 5 percent of tissue resected cT1c: Tumor identified by needle biopsy (eg, because of elevated PSA) cT2: if not able to select T2a, T2b or T2c: Tumor confined within prostate* cT2a: Tumor involves one-half of one lobe or less cT2b: Tumor involves more than one-half of one lobe but not both lobes cT2c: Tumor involves both lobes cT3: if not able to select T3a, T3b or T3c: Tumor extends through the prostate capsule cT3a: Extracapsular extension (unilateral or bilateral) cT3b: Tumor invades seminal vesicle(s) cT4: Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall cTX: Primary tumor cannot be assessed INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C0205210
Indicate the clinical nodal stage (per AJCC 7th)
Description

Pathologic staging preferred, if available cNo: regional lymph node metastasis cN1: Metastasis in regional lymph node(s) cNX: Regional lymph nodes were not assessed INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0456532
UMLS CUI [1,3]
C0205210
Indicate the pathological tumor stage (per AJCC 7th)
Description

Pathologic staging preferred, if available pT2: if not able to select T2a, T2b or T2c: Organ confined pT2a: Unilateral, one-half of one side or less pT2b: Unilateral, involving more than one-half of side but not both sides pT2c: Bilateral disease pT3: if not able to select T3a, T3b: Extraprostatic extension pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT4: Invasion of rectum, levator muscles, and/or pelvic wall pTX: Primary tumor cannot be assessed INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C1521733
Indicate the pathological nodal stage (per AJCC 7th)
Description

Pathologic staging preferred, if available pN0: No positive regional nodes pN1: Metastases in regional node(s) pNX: Regional nodes not sampled INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0456532
UMLS CUI [1,3]
C1521733
Indicate if a Gleason score was recorded at time of initial diagnosis
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0332326
If yes, indicate the primary Gleason score at time of initial diagnosis
Description

INCLUSION CRITERIA: All patients If answered 'yes' on Gleason score (GLEASON) TIMING: Baseline REPORTING SOUCE: Clinical RESPONSE OPTIONS: 2-10

Data type

integer

Alias
UMLS CUI [1]
C0332326
If yes, indicate the secondary Gleason score at time of initial diagnosis
Description

INCLUSION CRITERIA: All patients If answered 'yes' on Gleason score (GLEASON) TIMING: Baseline REPORTING SOUCE: Clinical RESPONSE OPTIONS: 2-10

Data type

integer

Alias
UMLS CUI [1]
C0332326
Provide site of metastatic disease
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0807944
Provide extent of metastatic disease
Description

High burden is indicated as any of the following criteria (from: CHAARTED (randomized clinical trial in the US): - Visceral metastases (extranodal) - Bone metastases with at least 4 bone lesions OR at least 1 bone lesion outside of the vertebral column or pelvis. INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0449279
Treatment Factors
Description

Treatment Factors

Indicate if the patient has had a prior prostatectomy
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0332152
UMLS CUI [1,2]
C0033573
Indicate date of prostatectomy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on prior prostatectomy (prostatectx) TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0332152
UMLS CUI [1,2]
C0033573
UMLS CUI [1,3]
C0011008
DD/MM/YYYY
Indicate if the patient has had prior radiation as primary treatment for prostate cancer (prostate bed, not palliative radiation)
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C1708063
Indicate if the patient has had prior radiation as adjuvant / salvage therapy for prostate cancer (prostate bed, not palliative radiation)
Description

INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C1706721
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0085405
Indicate if the patient has had treatment with ADT
Description

Use of any of the following treatments to induce castrate levels of serum testosterone: 1. LHRH or GnRH agonist or antagonist 2. Bilateral orchiectomies INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0279492
Indicate systemic therapies used in the past other than ADT
Description

Any medication that treats the prostate cancer taken by mouth, through a vein, or injected, other than ADT INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C1514463
Indicate the receipt of anti-resorptive medications or denosumab
Description

Both anti-resorptive medications or denosumab are relevant INCLUSION CRITERIA: All patients TIMING: Baseline REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C3839270
Treatment Variables
Description

Treatment Variables

Indicate if the patient received Androgen Deprivation Therapy
Description

INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0279492
Indicate date patient started Androgen Deprivation Therapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on Androgen Deprivation Therapy (ADTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0808070
DD/MM/YYYY
Indicate date patient stopped Androgen Deprivation Therapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on Androgen Deprivation Therapy (ADTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if Androgen Deprivation Therapy is ongoing
Description

INCLUSION CRITERIA: All patients If answered 'yes' on Androgen Deprivation Therapy (ADTX), and no end date is entered (ADTXSTOPDATE) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0549178
Indicate if the patient received hormonal treatment other than Androgen Deprivation Therapy
Description

INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0279025
Indicate date patient started hormonal treatment other than Androgen Deprivation Therapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on hormonal therapy (HORMONTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0808070
DD/MM/YYYY
Indicate date patient stopped hormonal treatment other than Androgen Deprivation Therapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on hormonal therapy (HORMONTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if hormonal therapy is ongoing
Description

INCLUSION CRITERIA: All patients If answered 'yes' on hormonal therapy (HORMONTX), and no end date is entered (HORMONTXSTOPDATE) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

integer

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0549178
Indicate if the patient received chemotherapy
Description

INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1]
C0392920
Indicate date patient started chemotherapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on chemotherapy (CHEMOTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C1302181
UMLS CUI [1,2]
C3173309
DD/MM/YYYY
Indicate date patient stopped chemotherapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on chemotherapy (CHEMOTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C1302181
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if chemotherapy is ongoing
Description

INCLUSION CRITERIA: All patients If answered 'yes' on chemotherapy (CHEMOTX), and no end date is entered (CHEMOTXSTOPDATE) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1,1]
C0549178
UMLS CUI [1,2]
C0392920
Indicate if the patient received immunotherapy
Description

INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1]
C0021083
Indicate date patient started immunotherapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on immunotherapy (IMMUNOTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0808070
DD/MM/YYYY
Indicate date patient stopped immunotherapy
Description

INCLUSION CRITERIA: All patients If answered 'yes' on immunotherapy (IMMUNOTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if immunotherapy is ongoing
Description

INCLUSION CRITERIA: All patients If answered 'yes' on immunotherapy (IMMUNOTX), and no end date is entered (IMMUNOTXSTOPDATE) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0549178
Indicate if the patient received radiopharmaceuticals
Description

INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1]
C0182638
Indicate date patient started radiopharmaceuticals
Description

INCLUSION CRITERIA: All patients If answered 'yes' on radiopharmaceuticals (RADIOPHARM) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0182638
UMLS CUI [1,2]
C3173309
DD/MM/YYYY
Indicate date patient stopped radiopharmaceuticals
Description

INCLUSION CRITERIA: All patients If answered 'yes' on radiopharmaceuticals (RADIOPHARM) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0182638
UMLS CUI [1,2]
C1531784
DD/MM/YYYY
Indicate if radiotherapy is ongoing
Description

INCLUSION CRITERIA: All patients If answered 'yes' on radiotherapy (RADIOTX), and no end date is entered (RADIOTXSTOPDATE) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1,1]
C0182638
UMLS CUI [1,2]
C0549178
Indicate if the patient received interventions for complications due to for local progression
Description

Could be one of the following procedures: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Multiple answer

Data type

integer

Alias
UMLS CUI [1,1]
C0184661
UMLS CUI [1,2]
C0027643
Indicate date patient received TURP intervention for complications due to for local progression
Description

INCLUSION CRITERIA: All patients If answered 'TURP' on interventions for complications due to local progression (LOCPROGTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0040771
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date patient received ureteral stent intervention for complications due to for local progression
Description

INCLUSION CRITERIA: All patients If answered 'ureteral stent' on interventions for complications due to local progression (LOCPROGTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0183518
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date patient received percutaneous nephrostomy tube intervention for complications due to for local progression
Description

INCLUSION CRITERIA: All patients If answered 'percutaneous nephrostomy tube' on interventions for complications due to local progression (LOCPROGTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0564457
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date patient received suprapubic catheter placement intervention for complications due to for local progression
Description

INCLUSION CRITERIA: All patients If answered 'suprapubic catheter placement' on interventions for complications due to local progression (LOCPROGTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0150798
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date patient received chronic foley catheter / self intermittent catheterization intervention for complications due to for local progression
Description

INCLUSION CRITERIA: All patients If answered 'chronic foley catheter / self intermittent catheterization' on interventions for complications due to local progression (LOCPROGTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0179804
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate if the patient received bisphosphonates or denosumab
Description

INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C1690432
Indicate date patient started bisphosphonates or denosumab
Description

INCLUSION CRITERIA: All patients If answered 'yes' on bisphosphonates or denosumab (BISPHOSTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0012544
UMLS CUI [1,2]
C0808070
UMLS CUI [2,1]
C1690432
UMLS CUI [2,2]
C0808070
DD/MM/YYYY
Indicate date patient stopped bisphosphonates or denosumab
Description

INCLUSION CRITERIA: All patients If answered 'yes' on bisphosphonates or denosumab (BISPHOSTX) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0012544
UMLS CUI [1,2]
C1690432
UMLS CUI [1,3]
C0806020
DD/MM/YYYY
Indicate if bisphosphonates or denosumab are ongoing
Description

INCLUSION CRITERIA: All patients If answered 'yes' on bisphosphonates or denosumab (BISPHOSTX), and no end date is entered (BISPHOSTXSTOPDATE) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1,1]
C0012544
UMLS CUI [1,2]
C0549178
UMLS CUI [2,1]
C1690432
UMLS CUI [2,2]
C0549178
Acute Complications of Treatment
Description

Acute Complications of Treatment

Indicate whether the patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment
Description

A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOUCE: Clinical TYPE: Multiple answer

Data type

integer

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1516728
UMLS CUI [1,3]
C1515119
Indicate the CTCAE v 4.0 grade III-IV complication the patient experienced
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered 'Other' on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical RESPONSE OPTIONS: CTCAE grade III-IV complication due to systemic therapy (excluding ADT)

Data type

text

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1516728
UMLS CUI [1,3]
C1515119
Indicate date of cytopenias
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered Cytopenias on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0010828
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of infection
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered Infection on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C2316983
DD/MM/YYYY
Indicate date of vomiting, diarrhea, constipation, or other GI toxicity
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered Vomiting, diarrhea, constipation, other GI toxicity on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0521362
UMLS CUI [1,3]
C0011008
DD/MM/YYYY
Indicate date of neuropathy
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered Neuropathy on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of cardiovascular toxicity
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered Cardiovascular toxicity on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C2316983
DD/MM/YYYY
Indicate date of other complication
Description

INCLUSION CRITERIA: Patients with systemic therapy If answered Other on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS) TIMING: Update at least annually REPORTING SOUCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Degree of health
Description

Degree of health

Indicate the ECOG/WHO performance status
Description

ECOG / WHO scale: - PS = 0 normal activity level; - PS = 1 restricted with strenuous activity, but can do light activity; - PS = 2 active >/= 50% of day; - PS = 3 spends >50% of day in chair or bed; - PS = 4 totally confined to bed INCLUSION CRITERIA: All patients TIMING: Baseline 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1,1]
C1520224
UMLS CUI [1,2]
C1298650
Indicate the ECOG/WHO performance status
Description

ECOG / WHO scale: - PS = 0 normal activity level; - PS = 1 restricted with strenuous activity, but can do light activity; - PS = 2 active >/= 50% of day; - PS = 3 spends >50% of day in chair or bed; - PS = 4 totally confined to bed INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Multiple answer

Data type

integer

Alias
UMLS CUI [1]
C0002771
This questionnaire is designed to measure Quality of Life issues in patients with Prostate cancer. To help us get the most accurate measurement, it is important that you answer all questions honestly and completely. Remember, as with all medical records, information contained within this survey will remain strictly confidential. 1: Over the past 4 weeks, how often have you leaked urine?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289637
2: Which of the following best describes your urinary control during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289645
3: How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289630
4a: How big a problem, if any, has the following been for you during the last 4 weeks? Dripping or leaking urine
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289641
4b: Pain or burning on urination
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289629
4c: Bleeding with urination
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289644
4d: Weak urine stream or incomplete emptying
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289625
4e: Need to urinate frequently during the day
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289626
5: Overall, how big a problem has your urinary function been for you during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289631
6a: How big a problem, if any, has the following been for you? Urgency to have a bowel movement
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289627
6b: Increased frequency of bowel movements
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289636
6c: Losing control of your stools
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289634
6d: Bloody stools
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4287870
6e: Abdominal/Pelvic/Rectal pain
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289649
7: Overall, how big a problem have your bowel habits been for you during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289633
8a: How would you rate the following during the last 4 weeks? Your ability to have an erection?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289647
8b: Your ability to reach orgasm (climax)?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289646
9: How would you describe the usual QUALITY of your erections during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289628
10: How would you describe the FREQUENCY of your erections during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289639
11: Overall, how would you rate your ability to function sexually during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289648
12: Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289632
13a: How big a problem during the last 4 weeks, if any, has the following been for you? Hot flashes
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289638
13b: Breast tenderness/enlargement
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289643
13c: Feeling depressed
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289640
13d: Lack of energy
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289635
13e: Change in body weight
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C4289642
During the last 4 weeks, to what extent were you interested in sex?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C3899191
Have you used any medications or devices to aid or improve erections?
Description

INCLUSION CRITERIA: All patients TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C3827672
For each of the following medicines or devices, please indicate whether or not you have tried or currently use it to improve your erections: Viagra or another pill
Description

INCLUSION CRITERIA: All patients If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02)TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0663448
Muse (intra-urethral alprostadil suppository)
Description

INCLUSION CRITERIA: All patients If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C2366566
Penile injection therapy (such as caverject)
Description

INCLUSION CRITERIA: All patients If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02)TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C3828613
Vacuum erection device (such as erect-aid)
Description

INCLUSION CRITERIA: All patients If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C3827672
Other medication/device
Description

INCLUSION CRITERIA: All patients If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline 3 months post initiation of treatment 6 months post initiation of treatment 1 year post initiation of treatment Tracked ongoing annually for life REPORTING SOUCE: Patient-reported TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C1115771
EORTCQLQC
Description

EORTCQLQC

EORTC QLQ-PR25
Description

EORTC QLQ-PR25

Data type

text

EORTC QLQ-C30
Description

EORTC QLQ-C30

Data type

text

Survival and disease control
Description

Survival and disease control

Indicate if patient received any of the following procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization
Description

INCLUSION CRITERIA: All patients If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer

Data type

integer

Alias
UMLS CUI [1,1]
C0184661
UMLS CUI [1,2]
C0449258
Indicate if the patient has a symptomatic fracture, cord compression or need for surgery or radiation to bone
Description

INCLUSION CRITERIA: All patients TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1]
C0242656
Indicate date of Symptomatic Skeletal Related Event
Description

INCLUSION CRITERIA: All patients If answered 'yes' on symptomatic skeletal related event (SSRE) TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C0037253
UMLS CUI [1,3]
C0011008
DD/MM/YYYY
Indicate if the patient was diagnosed with metastatic disease
Description

INCLUSION CRITERIA: Patients without known metastasis TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Single Answer

Data type

integer

Alias
UMLS CUI [1]
C2939420
Indicate date of metastasis
Description

INCLUSION CRITERIA: Patients without known metastasis If answered 'yes' on development of metastasis (METADEV) TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0027627
DD/MM/YYYY
Indicate if the patient was diagnosed with castration resistant disease
Description

Castration-resistant disease is defined as two successive PSA rises at least one week apart, or the development or progression of radiographically proven metastatic lesions, in the setting of castrate levels of testosterone (<50 ng/mL) INCLUSION CRITERIA: Patients that are not yet castration resistant TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C3658267
Indicate date of castration-resistant disease
Description

INCLUSION CRITERIA: Patients that are not yet castration resistant If answered 'yes' on development of castration-resistant disease (CRPCDATE) TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C3658267
UMLS CUI [1,2]
C2316983
DD/MM/YYYY
Indicate if the patient has died
Description

INCLUSION CRITERIA: All patients TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Administrative data (Death registry) TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0011065
Indicate date of death
Description

INCLUSION CRITERIA: All patients If answered 'yes' on overall survival (OVERALLSURV) TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Administrative data (Death registry)

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1]
C1148348
DD/MM/YYYY
Indicate if death is noted to be directly attributable to prostate cancer
Description

INCLUSION CRITERIA: All patients If answered 'yes' on overall survival (OVERALLSURV) TIMING: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Administrative data (Death registry) TYPE: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0007465
UMLS CUI [1,2]
C0596130
UMLS CUI [1,3]
C0600139
Back to the top of the page

Similar models

ICHOM Advanced Prostate Cancer

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Advanced Prostate Cancer
Patient ID
Item
Indicate the patient's medical record number
integer
C1269815 (UMLS CUI [1])
Item Group
Demographic factors
Date of birth
Item
What is your date of birth?
date
C0421451 (UMLS CUI [1])
Height
Item
Indicate height in centimeters or inches
integer
C0005890 (UMLS CUI [1])
Item
Indicate units of height
integer
C0005890 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Pathological nodal stage
Code List
Indicate units of height
CL Item
pN0  (0)
CL Item
pN1 (1)
CL Item
pNX (2)
CL Item
Unknown (999)
Weight
Item
Indicate weight in kilograms or pounds
integer
C0005910 (UMLS CUI [1])
Item
Indicate units of weight
integer
C0005910 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Gleason score recorded at time of initial diagnosis
Code List
Indicate units of weight
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Height
Item
What is your height in centimeters or inches?
integer
C0005890 (UMLS CUI [1])
Item
Indicate units of height
integer
C0005890 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Pathological nodal stage
Code List
Indicate units of height
CL Item
pN0  (0)
CL Item
pN1 (1)
CL Item
pNX (2)
CL Item
Unknown (999)
Weight
Item
What is your weight in kilograms or pounds?
integer
C0005910 (UMLS CUI [1])
Item
Indicate units of weight f
integer
C0005910 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Pathological tumor stage
Code List
Indicate units of weight f
CL Item
pT2  (1)
CL Item
pT2a  (2)
CL Item
pT2b  (3)
CL Item
pT2c  (4)
CL Item
pT3 (5)
CL Item
pT3a  (6)
CL Item
pT3b  (7)
CL Item
pT4  (8)
CL Item
pTX (9)
CL Item
Unknown (999)
Ethnicity
Item
Varies by country and should be determined by country (not for cross country comparison)
text
C0015031 (UMLS CUI [1])
Item
Please indicate highest level of schooling completed
integer
C0013658 (UMLS CUI [1])
Site of metastatic disease
Code List
Please indicate highest level of schooling completed
CL Item
No metastasis (0)
CL Item
Bone only (1)
CL Item
Lymph node only (2)
CL Item
Visceral only (3)
CL Item
Combination (4)
Item
What is your relationship status?
integer
C0024819 (UMLS CUI [1])
Extent of metastatic disease
Code List
What is your relationship status?
CL Item
No metastasis (0)
CL Item
Low burden (1)
CL Item
High burden (2)
Item
Which statement best describes your living arrangements?
integer
C0024819 (UMLS CUI [1])
Prior radiation therapy: Primary treatment
Code List
Which statement best describes your living arrangements?
CL Item
No (0)
CL Item
Yes, 1-3 years ago (1)
CL Item
Yes, > 3 years ago (2)
Item Group
Baseline Clinical Factors
Hemoglobin level at APC diagnosis
Item
Indicate hemoglobin level at time of APC diagnosis
integer
C0518015 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
Item
Have you been told by a doctor that you have any of the following?
integer
C0009488 (UMLS CUI [1])
Prior radiation therapy: Primary treatment
Code List
Have you been told by a doctor that you have any of the following?
CL Item
No (0)
CL Item
Yes, 1-3 years ago (1)
CL Item
Yes, > 3 years ago (2)
Pain score
Item
On a scale of 0 to 10, with 0 being no pain at all and 10 being the worst pain imaginable, please indicate your average pain over the last 7 days?
integer
C0582148 (UMLS CUI [1])
Item
Do you have a first degree relative (father, brother, son) with a prostate cancer diagnosis?
integer
C1532320 (UMLS CUI [1])
Pathological nodal stage
Code List
Do you have a first degree relative (father, brother, son) with a prostate cancer diagnosis?
CL Item
pN0  (0)
CL Item
pN1 (1)
CL Item
pNX (2)
CL Item
Unknown (999)
Item Group
Baseline Tumor Factors
PSA level at APC diagnosis
Item
Indicate PSA value at time of APC diagnosis
integer
C0201544 (UMLS CUI [1])
Item
Indicate the clinical tumor stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Gleason score recorded at time of initial diagnosis
Code List
Indicate the clinical tumor stage (per AJCC 7th)
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Item
Indicate the clinical nodal stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C0456532 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Gleason score recorded at time of initial diagnosis
Code List
Indicate the clinical nodal stage (per AJCC 7th)
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Item
Indicate the pathological tumor stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C1521733 (UMLS CUI [1,3])
Site of metastatic disease
Code List
Indicate the pathological tumor stage (per AJCC 7th)
CL Item
No metastasis (0)
CL Item
Bone only (1)
CL Item
Lymph node only (2)
CL Item
Visceral only (3)
CL Item
Combination (4)
Item
Indicate the pathological nodal stage (per AJCC 7th)
integer
C0600139 (UMLS CUI [1,1])
C0456532 (UMLS CUI [1,2])
C1521733 (UMLS CUI [1,3])
Pathological nodal stage
Code List
Indicate the pathological nodal stage (per AJCC 7th)
CL Item
pN0  (0)
CL Item
pN1 (1)
CL Item
pNX (2)
CL Item
Unknown (999)
Item
Indicate if a Gleason score was recorded at time of initial diagnosis
integer
C0332326 (UMLS CUI [1])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if a Gleason score was recorded at time of initial diagnosis
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Gleason score at time of initial diagnosis: Primary
Item
If yes, indicate the primary Gleason score at time of initial diagnosis
integer
C0332326 (UMLS CUI [1])
Gleason score at time of initial diagnosis: Secondary
Item
If yes, indicate the secondary Gleason score at time of initial diagnosis
integer
C0332326 (UMLS CUI [1])
Item
Provide site of metastatic disease
integer
C0807944 (UMLS CUI [1])
Site of metastatic disease
Code List
Provide site of metastatic disease
CL Item
No metastasis (0)
CL Item
Bone only (1)
CL Item
Lymph node only (2)
CL Item
Visceral only (3)
CL Item
Combination (4)
Item
Provide extent of metastatic disease
integer
C0449279 (UMLS CUI [1])
Extent of metastatic disease
Code List
Provide extent of metastatic disease
CL Item
No metastasis (0)
CL Item
Low burden (1)
CL Item
High burden (2)
Item Group
Treatment Factors
Item
Indicate if the patient has had a prior prostatectomy
integer
C0332152 (UMLS CUI [1,1])
C0033573 (UMLS CUI [1,2])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient has had a prior prostatectomy
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Date of prior prostatectomy
Item
Indicate date of prostatectomy
date
C0332152 (UMLS CUI [1,1])
C0033573 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
Indicate if the patient has had prior radiation as primary treatment for prostate cancer (prostate bed, not palliative radiation)
integer
C0279134 (UMLS CUI [1,1])
C1708063 (UMLS CUI [1,2])
Prior radiation therapy: Primary treatment
Code List
Indicate if the patient has had prior radiation as primary treatment for prostate cancer (prostate bed, not palliative radiation)
CL Item
No (0)
CL Item
Yes, 1-3 years ago (1)
CL Item
Yes, > 3 years ago (2)
Item
Indicate if the patient has had prior radiation as adjuvant / salvage therapy for prostate cancer (prostate bed, not palliative radiation)
integer
C0279134 (UMLS CUI [1,1])
C1706721 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0085405 (UMLS CUI [2,2])
Prior radiation therapy: Primary treatment
Code List
Indicate if the patient has had prior radiation as adjuvant / salvage therapy for prostate cancer (prostate bed, not palliative radiation)
CL Item
No (0)
CL Item
Yes, 1-3 years ago (1)
CL Item
Yes, > 3 years ago (2)
Item
Indicate if the patient has had treatment with ADT
integer
C0279492 (UMLS CUI [1])
Prior radiation therapy: Primary treatment
Code List
Indicate if the patient has had treatment with ADT
CL Item
No (0)
CL Item
Yes, with bilateral orchiectomies (1)
CL Item
Yes, with LHRH or GnRH agonist or antagonist in the past (2)
CL Item
Yes, with LHRH or GnRH agonist or antagonist currently (3)
Item
Indicate systemic therapies used in the past other than ADT
integer
C1515119 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Prior radiation therapy: Primary treatment
Code List
Indicate systemic therapies used in the past other than ADT
CL Item
No (0)
CL Item
Yes, 1 therapy used (1)
CL Item
Yes, 2 therapies used (2)
CL Item
Yes, ≥ 3 therapies used (3)
Item
Indicate the receipt of anti-resorptive medications or denosumab
integer
C0012544 (UMLS CUI [1])
C3839270 (UMLS CUI [2])
Gleason score recorded at time of initial diagnosis
Code List
Indicate the receipt of anti-resorptive medications or denosumab
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Item Group
Treatment Variables
Item
Indicate if the patient received Androgen Deprivation Therapy
integer
C0279492 (UMLS CUI [1])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient received Androgen Deprivation Therapy
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Start of Androgen Deprivation Therapy
Item
Indicate date patient started Androgen Deprivation Therapy
date
C0279492 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Stop of Androgen Deprivation Therapy
Item
Indicate date patient stopped Androgen Deprivation Therapy
date
C0279492 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if Androgen Deprivation Therapy is ongoing
integer
C0279492 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if Androgen Deprivation Therapy is ongoing
CL Item
Treatment ongoing (1)
Item
Indicate if the patient received hormonal treatment other than Androgen Deprivation Therapy
integer
C0279025 (UMLS CUI [1])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient received hormonal treatment other than Androgen Deprivation Therapy
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Start of hormonal therapy
Item
Indicate date patient started hormonal treatment other than Androgen Deprivation Therapy
date
C0279025 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Stop of hormonal therapy
Item
Indicate date patient stopped hormonal treatment other than Androgen Deprivation Therapy
date
C0279025 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if hormonal therapy is ongoing
integer
C0279025 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if hormonal therapy is ongoing
CL Item
Treatment ongoing (1)
Item
Indicate if the patient received chemotherapy
integer
C0392920 (UMLS CUI [1])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient received chemotherapy
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Start of chemotherapy
Item
Indicate date patient started chemotherapy
date
C1302181 (UMLS CUI [1,1])
C3173309 (UMLS CUI [1,2])
Stop of chemotherapy
Item
Indicate date patient stopped chemotherapy
date
C1302181 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if chemotherapy is ongoing
integer
C0549178 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if chemotherapy is ongoing
CL Item
Treatment ongoing (1)
Item
Indicate if the patient received immunotherapy
integer
C0021083 (UMLS CUI [1])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient received immunotherapy
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Start of immunotherapy
Item
Indicate date patient started immunotherapy
date
C0021083 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Stop of immunotherapy
Item
Indicate date patient stopped immunotherapy
date
C0021083 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if immunotherapy is ongoing
integer
C0021083 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if immunotherapy is ongoing
CL Item
Treatment ongoing (1)
Item
Indicate if the patient received radiopharmaceuticals
integer
C0182638 (UMLS CUI [1])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient received radiopharmaceuticals
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Start of treatment with radiopharmaceuticals
Item
Indicate date patient started radiopharmaceuticals
date
C0182638 (UMLS CUI [1,1])
C3173309 (UMLS CUI [1,2])
Stop of treatment with radiopharmaceuticals
Item
Indicate date patient stopped radiopharmaceuticals
date
C0182638 (UMLS CUI [1,1])
C1531784 (UMLS CUI [1,2])
Item
Indicate if radiotherapy is ongoing
integer
C0182638 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if radiotherapy is ongoing
CL Item
Treatment ongoing (1)
Item
Indicate if the patient received interventions for complications due to for local progression
integer
C0184661 (UMLS CUI [1,1])
C0027643 (UMLS CUI [1,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if the patient received interventions for complications due to for local progression
CL Item
TURP (transurethral resection of the prostate) (1)
CL Item
Ureteral stent (2)
CL Item
Percutaneous nephrostomy tube  (3)
CL Item
Suprapubic catheter placement (4)
CL Item
Chronic foley catheter / self intermittent catheterization (5)
Date of TURP intervention needed for local progression
Item
Indicate date patient received TURP intervention for complications due to for local progression
date
C0040771 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of ureteral stent intervention needed for local progression
Item
Indicate date patient received ureteral stent intervention for complications due to for local progression
date
C0183518 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of percutaneous nephrostomy tube intervention needed for local progression
Item
Indicate date patient received percutaneous nephrostomy tube intervention for complications due to for local progression
date
C0564457 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of suprapubic catheter placement intervention needed for local progression
Item
Indicate date patient received suprapubic catheter placement intervention for complications due to for local progression
date
C0150798 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of chronic foley catheter / self intermittent catheterization intervention needed for local progression
Item
Indicate date patient received chronic foley catheter / self intermittent catheterization intervention for complications due to for local progression
date
C0179804 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Indicate if the patient received bisphosphonates or denosumab
integer
C0012544 (UMLS CUI [1])
C1690432 (UMLS CUI [2])
Gleason score recorded at time of initial diagnosis
Code List
Indicate if the patient received bisphosphonates or denosumab
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Start of bisphosphonates or denosumab
Item
Indicate date patient started bisphosphonates or denosumab
date
C0012544 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C1690432 (UMLS CUI [2,1])
C0808070 (UMLS CUI [2,2])
Stop of bisphosphonates or denosumab
Item
Indicate date patient stopped bisphosphonates or denosumab
date
C0012544 (UMLS CUI [1,1])
C1690432 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
Item
Indicate if bisphosphonates or denosumab are ongoing
integer
C0012544 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C1690432 (UMLS CUI [2,1])
C0549178 (UMLS CUI [2,2])
Ongoing Androgen Deprivation Therapy
Code List
Indicate if bisphosphonates or denosumab are ongoing
CL Item
Treatment ongoing (1)
Item Group
Acute Complications of Treatment
Item
Indicate whether the patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment
integer
C0009566 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
CTCAE grade III-IV complications due to systemic therapy (excluding ADT)
Code List
Indicate whether the patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment
CL Item
No grade III-IV toxicity (0)
CL Item
Cytopenias (anemia, neutropenia, thrombocytopenia) (1)
CL Item
Infection, any primary site (2)
CL Item
Vomiting, diarrhea, constipation, other GI toxicity (3)
CL Item
Neuropathy, any type (4)
CL Item
Cardiovascular toxicity (heart attack, heart failure, arrhythmia) (5)
CL Item
Other (free text) (888)
CTCAE grade III-IV complication due to systemic therapy (excluding ADT) other than those explicitly listed
Item
Indicate the CTCAE v 4.0 grade III-IV complication the patient experienced
text
C0009566 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
Date of cytopenias
Item
Indicate date of cytopenias
date
C0010828 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of infection
Item
Indicate date of infection
date
C0009450 (UMLS CUI [1,1])
C2316983 (UMLS CUI [1,2])
Date of vomiting, diarrhea, constipation, or other GI toxicity
Item
Indicate date of vomiting, diarrhea, constipation, or other GI toxicity
date
C0009566 (UMLS CUI [1,1])
C0521362 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Date of neuropathy
Item
Indicate date of neuropathy
date
C0442874 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of cardiovascular toxicity
Item
Indicate date of cardiovascular toxicity
date
C0007222 (UMLS CUI [1,1])
C2316983 (UMLS CUI [1,2])
Date of other complication
Item
Indicate date of other complication
date
C0009566 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Degree of health
Item
Indicate the ECOG/WHO performance status
integer
C1520224 (UMLS CUI [1,1])
C1298650 (UMLS CUI [1,2])
ECOG/WHO performance status
Code List
Indicate the ECOG/WHO performance status
CL Item
0 (0)
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
Unknown (999)
Item
Indicate the ECOG/WHO performance status
integer
C0002771 (UMLS CUI [1])
ECOG/WHO performance status
Code List
Indicate the ECOG/WHO performance status
CL Item
No (0)
CL Item
Yes, over the counter or non-prescription pain medication (1)
CL Item
Yes, prescription pain medications (opioid or narcotic medications) (2)
Item
This questionnaire is designed to measure Quality of Life issues in patients with Prostate cancer. To help us get the most accurate measurement, it is important that you answer all questions honestly and completely. Remember, as with all medical records, information contained within this survey will remain strictly confidential. 1: Over the past 4 weeks, how often have you leaked urine?
integer
C4289637 (UMLS CUI [1])
Question 1 of EORTC-QLQ-C30
Code List
This questionnaire is designed to measure Quality of Life issues in patients with Prostate cancer. To help us get the most accurate measurement, it is important that you answer all questions honestly and completely. Remember, as with all medical records, information contained within this survey will remain strictly confidential. 1: Over the past 4 weeks, how often have you leaked urine?
CL Item
More than once a day (1)
CL Item
About once a day (2)
CL Item
More than once a week (3)
CL Item
About once a week (4)
CL Item
Rarely or never (5)
Item
2: Which of the following best describes your urinary control during the last 4 weeks?
integer
C4289645 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
2: Which of the following best describes your urinary control during the last 4 weeks?
CL Item
No urinary control whatsoever (1)
CL Item
Frequent dribbling (2)
CL Item
Occasional dribbling (3)
CL Item
Total control (4)
Item
3: How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks?
integer
C4289630 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
3: How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks?
CL Item
1 pad per day (1)
CL Item
2 pads per day (2)
CL Item
3 or more pads per day (3)
CL Item
None (0)
Item
4a: How big a problem, if any, has the following been for you during the last 4 weeks? Dripping or leaking urine
integer
C4289641 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
4a: How big a problem, if any, has the following been for you during the last 4 weeks? Dripping or leaking urine
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
4b: Pain or burning on urination
integer
C4289629 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
4b: Pain or burning on urination
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
4c: Bleeding with urination
integer
C4289644 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
4c: Bleeding with urination
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
4d: Weak urine stream or incomplete emptying
integer
C4289625 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
4d: Weak urine stream or incomplete emptying
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
4e: Need to urinate frequently during the day
integer
C4289626 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
4e: Need to urinate frequently during the day
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
5: Overall, how big a problem has your urinary function been for you during the last 4 weeks?
integer
C4289631 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
5: Overall, how big a problem has your urinary function been for you during the last 4 weeks?
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
6a: How big a problem, if any, has the following been for you? Urgency to have a bowel movement
integer
C4289627 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
6a: How big a problem, if any, has the following been for you? Urgency to have a bowel movement
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
6b: Increased frequency of bowel movements
integer
C4289636 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
6b: Increased frequency of bowel movements
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
6c: Losing control of your stools
integer
C4289634 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
6c: Losing control of your stools
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
6d: Bloody stools
integer
C4287870 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
6d: Bloody stools
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
6e: Abdominal/Pelvic/Rectal pain
integer
C4289649 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
6e: Abdominal/Pelvic/Rectal pain
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
7: Overall, how big a problem have your bowel habits been for you during the last 4 weeks?
integer
C4289633 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
7: Overall, how big a problem have your bowel habits been for you during the last 4 weeks?
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
No problem (0)
CL Item
Big problem (4)
Item
8a: How would you rate the following during the last 4 weeks? Your ability to have an erection?
integer
C4289647 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
8a: How would you rate the following during the last 4 weeks? Your ability to have an erection?
CL Item
Very poor to none (1)
CL Item
Poor (2)
CL Item
Fair (3)
CL Item
Good (4)
CL Item
Very good (5)
Item
8b: Your ability to reach orgasm (climax)?
integer
C4289646 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
8b: Your ability to reach orgasm (climax)?
CL Item
Very poor to none (1)
CL Item
Poor (2)
CL Item
Fair (3)
CL Item
Good (4)
CL Item
Very good (5)
Item
9: How would you describe the usual QUALITY of your erections during the last 4 weeks?
integer
C4289628 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
9: How would you describe the usual QUALITY of your erections during the last 4 weeks?
CL Item
None at all (1)
CL Item
Not firm enough for any sexual activity (2)
CL Item
Firm enough for masturbation and foreplay only (3)
CL Item
Firm enough for intercourse (4)
Item
10: How would you describe the FREQUENCY of your erections during the last 4 weeks?
integer
C4289639 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
10: How would you describe the FREQUENCY of your erections during the last 4 weeks?
CL Item
I NEVER had an erection when I wanted one (1)
CL Item
I had an erection LESS THAN HALF the time I wanted one (2)
CL Item
I had an erection ABOUT HALF the time I wanted one (3)
CL Item
I had an erection MORE THAN HALF the time I wanted one (4)
CL Item
I had an erection WHENEVER I wanted one (5)
Item
11: Overall, how would you rate your ability to function sexually during the last 4 weeks?
integer
C4289648 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
11: Overall, how would you rate your ability to function sexually during the last 4 weeks?
CL Item
Very poor (1)
CL Item
Poor (2)
CL Item
Fair (3)
CL Item
Good (4)
CL Item
Very good (5)
Item
12: Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks?
integer
C4289632 (UMLS CUI [1])
Question 2 of EPIC-26
Code List
12: Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks?
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
Big problem (4)
CL Item
No problem (0)
Item
13a: How big a problem during the last 4 weeks, if any, has the following been for you? Hot flashes
integer
C4289638 (UMLS CUI [1])
Question 13a of EPIC-26
Code List
13a: How big a problem during the last 4 weeks, if any, has the following been for you? Hot flashes
CL Item
No problem (0)
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
Big problem (4)
Item
13b: Breast tenderness/enlargement
integer
C4289643 (UMLS CUI [1])
Question 13a of EPIC-26
Code List
13b: Breast tenderness/enlargement
CL Item
No problem (0)
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
Big problem (4)
Item
13c: Feeling depressed
integer
C4289640 (UMLS CUI [1])
Question 13a of EPIC-26
Code List
13c: Feeling depressed
CL Item
No problem (0)
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
Big problem (4)
Item
13d: Lack of energy
integer
C4289635 (UMLS CUI [1])
Question 13a of EPIC-26
Code List
13d: Lack of energy
CL Item
No problem (0)
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
Big problem (4)
Item
13e: Change in body weight
integer
C4289642 (UMLS CUI [1])
Question 13a of EPIC-26
Code List
13e: Change in body weight
CL Item
No problem (0)
CL Item
Very small problem (1)
CL Item
Small problem (2)
CL Item
Moderate problem (3)
CL Item
Big problem (4)
Item
During the last 4 weeks, to what extent were you interested in sex?
integer
C3899191 (UMLS CUI [1])
Question 1 of additional libido and use of sexual aids questions
Code List
During the last 4 weeks, to what extent were you interested in sex?
CL Item
Not at all (0)
CL Item
A little (1)
CL Item
Quite a bit (2)
CL Item
Very much (3)
Item
Have you used any medications or devices to aid or improve erections?
integer
C3827672 (UMLS CUI [1])
Question 2 of additional libido and use of sexual aids questions
Code List
Have you used any medications or devices to aid or improve erections?
CL Item
No (0)
CL Item
Yes (1)
Item
For each of the following medicines or devices, please indicate whether or not you have tried or currently use it to improve your erections: Viagra or another pill
integer
C0663448 (UMLS CUI [1])
Question 3a of additional libido and use of sexual aids questions
Code List
For each of the following medicines or devices, please indicate whether or not you have tried or currently use it to improve your erections: Viagra or another pill
CL Item
Have not tried it (0)
CL Item
Tried it but was not helpful (1)
CL Item
It helped but I am not using it now (2)
CL Item
It helped and I use it sometimes (3)
CL Item
It helped and I use it always (4)
Item
Muse (intra-urethral alprostadil suppository)
integer
C2366566 (UMLS CUI [1])
Question 3a of additional libido and use of sexual aids questions
Code List
Muse (intra-urethral alprostadil suppository)
CL Item
Have not tried it (0)
CL Item
Tried it but was not helpful (1)
CL Item
It helped but I am not using it now (2)
CL Item
It helped and I use it sometimes (3)
CL Item
It helped and I use it always (4)
Item
Penile injection therapy (such as caverject)
integer
C3828613 (UMLS CUI [1])
Question 3a of additional libido and use of sexual aids questions
Code List
Penile injection therapy (such as caverject)
CL Item
Have not tried it (0)
CL Item
Tried it but was not helpful (1)
CL Item
It helped but I am not using it now (2)
CL Item
It helped and I use it sometimes (3)
CL Item
It helped and I use it always (4)
Item
Vacuum erection device (such as erect-aid)
integer
C3827672 (UMLS CUI [1])
Question 3a of additional libido and use of sexual aids questions
Code List
Vacuum erection device (such as erect-aid)
CL Item
Have not tried it (0)
CL Item
Tried it but was not helpful (1)
CL Item
It helped but I am not using it now (2)
CL Item
It helped and I use it sometimes (3)
CL Item
It helped and I use it always (4)
Item
Other medication/device
integer
C1115771 (UMLS CUI [1])
Question 3a of additional libido and use of sexual aids questions
Code List
Other medication/device
CL Item
Have not tried it (0)
CL Item
Tried it but was not helpful (1)
CL Item
It helped but I am not using it now (2)
CL Item
It helped and I use it sometimes (3)
CL Item
It helped and I use it always (4)
Item Group
EORTCQLQC
EORTC QLQ-PR25
Item
EORTC QLQ-PR25
text
EORTC QLQ-C30
Item
EORTC QLQ-C30
text
Item Group
Survival and disease control
Item
Indicate if patient received any of the following procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization
integer
C0184661 (UMLS CUI [1,1])
C0449258 (UMLS CUI [1,2])
Procedures needed for local progression
Code List
Indicate if patient received any of the following procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization
CL Item
None of the procedures (0)
CL Item
TURP (transurethral resection of the prostate) (1)
CL Item
Ureteral stent (2)
CL Item
Percutaneous nephrostomy tube  (3)
CL Item
Suprapubic catheter placement (4)
CL Item
Chronic foley catheter / self intermittent catheterization (5)
Item
Indicate if the patient has a symptomatic fracture, cord compression or need for surgery or radiation to bone
integer
C0242656 (UMLS CUI [1])
Question 2 of additional libido and use of sexual aids questions
Code List
Indicate if the patient has a symptomatic fracture, cord compression or need for surgery or radiation to bone
CL Item
No (0)
CL Item
Yes (1)
Date of symptomatic skeletal related event
Item
Indicate date of Symptomatic Skeletal Related Event
date
C0441471 (UMLS CUI [1,1])
C0037253 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
Indicate if the patient was diagnosed with metastatic disease
integer
C2939420 (UMLS CUI [1])
Question 2 of additional libido and use of sexual aids questions
Code List
Indicate if the patient was diagnosed with metastatic disease
CL Item
No (0)
CL Item
Yes (1)
Date of diagnosed metastasis
Item
Indicate date of metastasis
date
C2316983 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Item
Indicate if the patient was diagnosed with castration resistant disease
integer
C3658267 (UMLS CUI [1])
Question 2 of additional libido and use of sexual aids questions
Code List
Indicate if the patient was diagnosed with castration resistant disease
CL Item
No (0)
CL Item
Yes (1)
Date of castration-resistant disease
Item
Indicate date of castration-resistant disease
date
C3658267 (UMLS CUI [1,1])
C2316983 (UMLS CUI [1,2])
Item
Indicate if the patient has died
integer
C0011065 (UMLS CUI [1])
Question 2 of additional libido and use of sexual aids questions
Code List
Indicate if the patient has died
CL Item
No (0)
CL Item
Yes (1)
Death: Date of death
Item
Indicate date of death
date
C1148348 (UMLS CUI [1])
Item
Indicate if death is noted to be directly attributable to prostate cancer
integer
C0007465 (UMLS CUI [1,1])
C0596130 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
Cause of death: Death attributable to advanced prostate cancer
Code List
Indicate if death is noted to be directly attributable to prostate cancer
CL Item
No (0)
CL Item
Yes (1)
CL Item
Unknown (999)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial